Candidature YC de Kernal Biologics

Summer 2020Active

Kernal Biologics a été sélectionné par Y Combinator dans le cadre du batch Summer 2020 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC: Summer 2020
Secteur d'activité: HealthcareTherapeutics
Taille de l'équipe: 20
Statut: Active
Lancé: 2020

Fondateurs

Yusuf ErkulFounder
Jeff OzdemirFounder
Burak YILMAZFounder

Ce que fait Kernal Biologics

Kernal Bio is a biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted cell delivery and minimal off-target effects. Our KR-402 program achieves over 90% delivery efficiency with T-cell-targeted LNPs, enabling direct CAR-T programming within the body and resulting in B-cell depletion within a week. Kernal Bio is led by a team with experience from MIT, Harvard, Merck, and BMS, boasting three FDA-approved therapies and over 120 patents. Based in Cambridge, MA, we are backed by Hummingbird Ventures, Amgen Ventures, HBM, and even NASA. With roots at MIT, Harvard and Biopharma, Kernal’s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. Sr. VP of R&D Manfred Kraus is a leader in immuno-oncology, who was most recently Scientific Sr. Director at Bristol-Myers Squibb (BMS).

Candidature YC de Kernal Biologics, reconstruite

Candidature Y Combinator

Kernal Biologics, promotion Summer 2020. Les vraies questions de candidature, répondues à partir de données publiques.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Kernal Biologics

Describe what your company does in 50 characters or less.

mRNA 2.0 therapies targeting specific cells

What is your company going to make? Please describe your product and what it does or will do.

We're building selective mRNA-LNP immunotherapies that deliver mRNA precisely to specific immune cells. Our lead program, KR-402, targets T cells to program CAR-T therapies directly in the body and can deplete B cells within a week. This lets us treat cancer and autoimmune diseases with fewer off-target effects than current mRNA approaches.

Where do you live now, and where would the company be based after YC?

We live in Cambridge, MA, and Kernal is based there. After YC, we'd remain in Cambridge because that's where our team, science, and investors are concentrated.

Explain your decision regarding location.

Cambridge is a biotech hub with access to top academic talent and proximity to investors, which is critical for developing complex mRNA therapeutics. Being near MIT and Harvard also helps us recruit and collaborate on cutting-edge science.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Voir la candidature complète

Questions fréquemment posées

Est-ce la vraie candidature YC de Kernal Biologics ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Kernal Biologics (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Kernal Biologics se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC Kernal Biologics appartenait-il ?

Kernal Biologics faisait partie du batch Summer 2020 de Y Combinator.

Qui a fondé Kernal Biologics ?

Kernal Biologics a été fondé par Yusuf Erkul, Jeff Ozdemir, Burak YILMAZ.

Que fait Kernal Biologics ?

Kernal is creating mRNA 2.0 therapies that work in specific cells

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de Kernal Biologics en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.